Hundreds of proteins are inserted post-translationally into the endoplasmic reticulum (ER) membrane by a single carboxyterminal transmembrane domain (TMD) 1 . During targeting through the cytosol, the hydrophobic TMD of these tail-anchored (TA) proteins requires constant chaperoning to prevent aggregation or inappropriate interactions. A central component of this targeting system is TRC40, a conserved cytosolic factor that recognizes the TMD of TA proteins and delivers them to the ER for insertion 2-4 . The mechanism that permits TRC40 to find and capture its TA protein cargos effectively in a highly crowded cytosol is unknown. Here we identify a conserved three-protein complex composed of Bat3, TRC35 and Ubl4A that facilitates TA protein capture by TRC40. This Bat3 complex is recruited to ribosomes synthesizing membrane proteins, interacts with the TMDs of newly released TA proteins, and transfers them to TRC40 for targeting. Depletion of the Bat3 complex allows non-TRC40 factors to compete for TA proteins, explaining their mislocalization in the analogous yeast deletion strains 5-7 . Thus, the Bat3 complex acts as a TMD-selective chaperone that effectively channels TA proteins to the TRC40 insertion pathway.
Hundreds of proteins are inserted post-translationally into the endoplasmic reticulum (ER) membrane by a single carboxyterminal transmembrane domain (TMD) 1 . During targeting through the cytosol, the hydrophobic TMD of these tail-anchored (TA) proteins requires constant chaperoning to prevent aggregation or inappropriate interactions. A central component of this targeting system is TRC40, a conserved cytosolic factor that recognizes the TMD of TA proteins and delivers them to the ER for insertion [2] [3] [4] . The mechanism that permits TRC40 to find and capture its TA protein cargos effectively in a highly crowded cytosol is unknown. Here we identify a conserved three-protein complex composed of Bat3, TRC35 and Ubl4A that facilitates TA protein capture by TRC40. This Bat3 complex is recruited to ribosomes synthesizing membrane proteins, interacts with the TMDs of newly released TA proteins, and transfers them to TRC40 for targeting. Depletion of the Bat3 complex allows non-TRC40 factors to compete for TA proteins, explaining their mislocalization in the analogous yeast deletion strains [5] [6] [7] . Thus, the Bat3 complex acts as a TMD-selective chaperone that effectively channels TA proteins to the TRC40 insertion pathway.
The final step in TA protein targeting to the mammalian ER is mediated by TRC40 (also called Asna1) 2, 4 . This factor interacts directly with TA substrates through their TMD, and on targeting to the ER membrane by means of putative receptor(s) it releases the TA protein in an ATPase-dependent manner for insertion into the lipid bilayer. The yeast homologue of TRC40, termed Get3, has an analogous function in conjunction with its ER receptors Get1 and Get2 (ref. 3) , and still poorly understood cytosolic factors Get4 and Get5 (refs 5-10) . In both cases, TRC40/Get3 must selectively and efficiently capture TA proteins by recognizing a hydrophobic TMD that is prone to aggregation, inappropriate interactions, or sequestration by other chaperones.
To investigate how TRC40 captures its TA protein cargo efficiently, we reconstituted this event in vitro and analysed its requirements ( Supplementary Fig. 1 ). Sucrose-gradient-purified ribosome-nascent chains (RNCs) containing a transfer-RNA-tethered TA protein (Sec61b) were released with puromycin in the presence of cytosolic fractions. Capture of the radiolabelled Sec61b by TRC40 was assayed by crosslinking. As expected, Sec61b released into a complete cytosol was captured by TRC40 in a TMD-dependent and energy-stimulated manner. TRC40 in size-fractionated cytosol was unable to capture Sec61b, which instead crosslinked to an unidentified protein that we provisionally term p38 ( Supplementary Fig. 2 ). TRC40 capture could be restored by adding back one of the missing fractions. Further fractionation confirmed that this 'capture-stimulating' factor is distinct from TRC40 ( Supplementary Fig. 3 ). Thus, efficient substrate capture by TRC40 in a complex environment requires an additional protein factor whose absence leads to substrate interactions with non-TRC40 proteins (for example, p38) despite the availability of TRC40.
We postulated that the capture-stimulating factor could be an intermediary that delivers substrates to TRC40. Such a factor should recognize TA substrates in a TMD-dependent manner, be found in fractions that contain 'capture-stimulating' activity, and be observed more easily on TRC40 saturation. Crosslinking analyses of Sec61b overproduced in complete cytosol revealed two interacting partners of about 120 kDa and 35 kDa that met these criteria ( Supplementary  Fig. 4 ). Our earlier affinity purification of Sec61b from large-scale translation reactions 2 contained an associated product of about 120 kDa (in addition to the major TRC40 band) that we identified by mass spectrometry as Bat3 (also known as Scythe/Bag6) (Supplementary Fig. 5 ). Bat3 affinity-purified from reticulocyte lysate co-purified with proteins of about 18 kDa and 35 kDa ( Fig. 1a ), which we identified by mass spectrometry as Ubl4A and C7ORF20; for the latter of these we propose the name TRC35 ( Supplementary  Fig. 5 ). Antibodies against Bat3, Ubl4A or TRC35 could co-immunoprecipitate the other two components, and affinity-depletion of any one of these components resulted in substantial depletion of the other two proteins ( Supplementary Fig. 6 ). Thus, Bat3 is part of a stable heterotrimeric complex in the cytosol.
The TMD-dependent interaction of the Bat3 complex with TA proteins was verified by immunoblotting of Sec61b affinity-purified from in vitro translation reactions ( Fig. 1b ). Furthermore, the TMDdependent 120-kDa and 35-kDa proteins crosslinked to Sec61b (Supplementary Fig. 4 ) could be specifically immunoprecipitated under denaturing conditions with anti-Bat3 and anti-TRC35 antibodies, respectively, or under non-denaturing conditions by anti-Ubl4A antibodies ( Fig. 1c ). Analysis of additional TA-protein TMDs by crosslinking showed that both TRC40 and the Bat3 complex interacted with the ER-targeted VAMP2 and Sed5 TMDs, whereas neither interacted with the TMDs from spontaneously inserting cytochrome b5 (Cb5) or mitochondrially targeted Fis1 or F1L ( Fig. 1d ). Differences in TMD hydrophobicity (either length or maximal hydrophobicity) among these substrates seemed to be a key determinant, because altering Sec61b TMD hydrophobicity to match that of Cb5, Fis1 or F1L markedly decreased the interaction with both the Bat3 complex and TRC40 ( Fig. 1e , f, and Supplementary Fig. 7 ). Thus, the Bat3 complex interacts directly with the TMDs of several ER-targeted TA proteins with similar substrate specificity to that of TRC40.
We surmised that the Bat3 complex was responsible for the stimulatory activity needed by TRC40 for efficient substrate capture. In cytosolic fractions that had been immunodepleted (by about 95%) of Bat3 (which also depletes Ubl4A and TRC35 without affecting TRC40 levels; Fig. 2a and Supplementary Fig. 6 ), Sec61b capture by TRC40 was diminished, with a concomitant increase in capture by p38 ( Fig. 2b) ; a similar effect was seen with TRC40-immunodepleted extracts, in which p38 was the primary soluble interaction partner. Replenishment of Bat3-depleted extracts to the original level with affinity-purified Bat3 complex (prepared by using an anti-TRC35 antibody ( Supplementary Fig. 8 )) fully restored TRC40 capture activity (Fig. 2b ). The effect of Bat3 depletion on TRC40 substrate capture was not simply a consequence of the RNC-release assay, because translation of full-length TA substrate in Bat3-depleted reticulocyte lysate also showed diminished TRC40 interactions with increased p38 interaction ( Supplementary Fig. 9 ). Thus, maximally efficient capture by TRC40 of TA proteins after their release from the ribosome requires the Bat3 complex. These findings are consistent with recent observations suggesting that depletion of Bat3 can impair the insertion of a TRC40-dependent TA protein 11 .
Although the biochemical functions of Bat3, Ubl4A and TRC35 are poorly understood, the latter two proteins have recognizable homologues in yeast (Mdy2/TMA24/Get5 and Yor164C/Get4, respectively) that have been analysed by recent biochemical, structural and genetic studies [5] [6] [7] 12, 13 . Get4 and Get5 form a stable complex that can interact with Get3, the yeast TRC40 homologue 5,7-10,12,13 . Deletion strains of Get4 and Get5 seem to phenocopy Get1, Get2 or Get3 deletions [5] [6] [7] , and all five genes cluster together in synthetic genetic interaction arrays 5, 7 . These observations have implicated Get4 and Get5 in TA insertion at a step before Get3, but their functions have been unclear.
Given that the Bat3 complex facilitates TRC40-substrate interactions, we speculated that the Bat3 complex might capture TA substrates at the ribosome and transfer them to TRC40. Such a model would require the Bat3 complex to be at or near the ribosome. Indeed, affinity-purified RNCs containing a TA protein were markedly enriched in the Bat3 complex relative to empty ribosomes ( Fig. 3a,  b ). Quantification showed that the Bat3 complex and signal recognition particle (SRP) occupy about 27% and about 7%, respectively, of TMD-containing RNCs (Fig. 3c ). For comparison, SRP occupancy on a genuine SRP substrate isolated by the same method was about 30% Supplementary Fig. 4 ) were immunoprecipitated under denaturing or native conditions. Non-immune serum (N.I.S.) was included as a control. d, Versions of Sec61b containing the TMD from the indicated proteins were analysed for interaction with Bat3 and TRC40 by in vitro translation, crosslinking and immunoprecipitation. An aliquot of the total translation reaction is shown for each substrate, as well as the immunoprecipitation products of the crosslinking reactions. The Sec61b crosslinked adducts are indicated by 'bx'. e, The TMD of Sec61b was mutated as indicated to change its hydrophobicity. f, Each construct was analysed for its interactions with the Bat3 complex and TRC40 as in b. An aliquot of the total translation product was analysed by autoradiography to reveal the substrates. a, Translation extracts were passed over anti-green fluorescent protein (anti-GFP; control), anti-Bat3 or anti-TRC40 affinity resins and different amounts of each depleted lysate were analysed by immunoblotting. b, Substrate capture assay using either total cytosol, or cytosol immunodepleted (D) with the indicated affinity resins. In this assay (see Supplementary Fig. 1 ), radiolabelled Sec61b RNCs were released with puromycin, and capture by TRC40 was assessed by crosslinking. The portion of gel showing the TRC40-Sec61b crosslink is shown. Failure of TRC40 to capture substrate typically results in capture by a 38-kDa protein (p38). The 'addback' lanes are Bat3-depleted cytosol replenished with affinity-purified Bat3 complex (prepared with an anti-TRC35 resin; Supplementary Fig. 8 ) at three concentrations spanning that present in the original cytosol. The 'mock' addback sample was prepared in parallel but employed an irrelevant affinity resin (anti-GFP) in place of TRC35 affinity resin ( Supplementary Fig. 8 ). A reaction lacking crosslinker (XL) is shown in the left-hand lane. Aliquots of each reaction (before crosslinking) were also analysed by immunoblotting against Bat3 and TRC40 to document their relative amounts in the reactions. Supplementary Fig. 10 ). The Bat3 complex occupies less than 5% of either empty ribosomes or RNCs containing a mutant TMD, illustrating substrate selectivity for the Bat3 complex recruitment. We confirmed that our affinity-purified RNC preparations were associated with tRNA, as judged by their sensitivity to alkaline hydrolysis and selective precipitation with cetyl trimethylammonium bromide (CTAB) ( Supplementary Fig. 11 ). Selective enrichment of the Bat3 complex on TA-protein RNCs was also seen with a magnetic bead 'pull-up' strategy that minimizes the non-specific recovery of aggregates ( Supplementary Fig. 12 ). Thus, as suggested for SRP 14 , the Bat3 complex seems to be recruited to ribosomes when a functional TMD is inside the ribosomal exit tunnel.
Analysis of various TMDs for their capacity to recruit the Bat3 complex and SRP to the ribosome from inside the tunnel showed a general correlation with hydrophobicity, with genuine ER-targeted TMDs (from Sec61b, VAMP2 and Sed5) showing the highest recruitment ( Supplementary Fig. 10 ). However, a strict concordance seems unlikely, because a moderately hydrophobic Sec61b mutant (3A3G) that fails to interact with the Bat3 complex post-translationally ( Fig. 1f ) nonetheless mediated its recruitment from inside the ribosome ( Supplementary Fig. 10 ). The Bat3 complex did not crosslink to ribosome-tethered substrate ( Supplementary Fig. 13 ), but only after release with puromycin or translational termination. This behaviour is opposite to that of SRP, which contacts substrates on the ribosome, but not after release. Thus, ribosomes synthesizing TMD-containing proteins can recruit both SRP and the Bat3 complex at a stage before the emergence of the TMD into the cytosol. Both of these complexes stay on the ribosome during further translation ( Supplementary Fig.  10 ), but after substrate release only the Bat3 complex remains associated in a TMD-dependent manner. Because changes in SRP recruitment do not influence Bat3 recovery on RNCs, the two factors may not compete with each other. However, this remains to be determined, because the binding site for the Bat3 complex is not known.
Selective recruitment of the Bat3 complex to ribosomes before TA protein release suggested that this might be the site of initial substrate capture. We therefore looked for a substrate-Bat3-ribosome intermediate after TRC40 depletion. Sec61b translated in a TRC40-depleted lysate was about 70% ribosome-associated, in which state it could be crosslinked to Bat3 (Fig. 3d ). When recombinant TRC40 was included in the depleted translation extract, the proportion of Sec61b in the ribosome fraction was decreased to about 30%, crosslinking to Bat3 was lost, and Sec61b in the soluble fraction was crosslinked to TRC40. Non-ribosomal Sec61b-Bat3 complexes can also transfer substrate to TRC40, because incubation of this fraction with TRC40-containing fractions resulted in a decrease in Bat3 crosslinks and a concomitant increase in TRC40 crosslinks (data not shown). Thus, the Bat3 complex is recruited to the ribosome, where it can interact with TA substrates after their translational termination. This putative Bat3-substrate intermediate, whether on the ribosome or free in solution, is then converted into the productive Sec61b-TRC40 targeting complex. Consistent with this model was our finding that Bat3 and TRC40 can interact, as determined by their co-immunoprecipitation under detergent-free conditions (Fig. 3e ).
Recruitment of Bat3 to RNCs is restricted to the period between synthesis of the TMD and release from the ribosome (Fig. 4a) , a time window that seems exceedingly brief. To explain this conundrum, we measured the recruitment window by performing a time course of TA protein synthesis combined with selective precipitation of tRNAassociated polypeptides with CTAB. Nascent chains available for recruitment of the Bat3 complex would be nearly full-length but would still contain a covalent tRNA. After confirming that these tRNA-associated full-length species can be selectively recovered ( Supplementary Fig. 14) , we quantified the amount of this population during a time course of Sec61b synthesis. At 5 min into this time course (about 2 min after full-length Sec61b chains were first detected), 50% of full-length Sec61b was precipitated by CTAB (Fig. 4b ). This proportion diminished over time as translational termination ensued and completed Sec61b chains accumulated. Comparison of experimental data with theoretical expectations ( Supplementary Fig. 15 ) yielded an estimated t 1/2 for Sec61b termination of about 1 min.
Remarkably, Sec61b-DTMD (lacking the TMD) showed substantially less tRNA-associated polypeptide at each time point (Fig. 4b ), corresponding to a termination t 1/2 of about 15 s. The last 12 codons (containing an epitope tag) of both constructs are identical, arguing against differences in residues close to the peptidyl transferase centre as the basis for differences in termination rate. The translation elongation rate (about 1.5-1.8 s per residue) and the roughly tenfold slower termination rate (relative to elongation) that we measured for to TRC40. a, Ribosomes were purified under native conditions from reticulocyte lysate and analysed for TRC40, Bat3, Ubl4A and SRP54 by immunoblotting. About 30-50% of SRP, 2-5% of Bat3 complex, and undetectable (less than 1%) amounts of TRC40 are ribosome-bound. b, Affinity-purifed and size-purified RNCs (from 60-ml translation reactions) of Sec61b, a TMD-lacking version (DTMD) and the 3R mutant were analysed by immunoblotting for the indicated antigens. For comparison, 0.5 ml of translation lysate was analysed. L9 is a ribosomal protein. Autoradiography confirmed equal recovery of each substrate. c, The amounts of ribosomes, Ubl4A and SRP54 were quantified in total lysate, purified empty ribosomes and purified RNC preparations. Shown are the amounts of SRP54 and Ubl4A, normalized to 100 ribosomes, averaged from multiple independent purifications (n 5 3 for empty ribosomes, n 5 7 for Sec61b-RNCs, and n 5 6 for b(3R)-RNCs). d, Translations of Sec61b in TRC40-depleted lysates lacking or replenished with recombinant zebrafish TRC40 were rapidly diluted, crosslinked and separated by centrifugation into soluble and ribosome fractions. Sec61b, Bat3 crosslinks (immunopreciptiated with anti-Bat3) and TRC40 crosslinks are shown in the total (T), soluble (S) and ribosome (P) fractions. e, Cytosolic fractions from HT1080 cells lacking or stably overexpressing haemagglutinin (HA)-tagged human TRC40 were bound to anti-HA resin and selectively eluted with tobacco etch virus (TEV) protease (which cleaves between the HA tag and TRC40). The eluted products, along with starting lysates, were analysed by immunoblotting for Bat3, TRC40 or small glutamine-rich tetratricopeptide repeat-containing protein a (SGTA; a control protein). Note that endogenous TRC40 is present but not visible at this exposure of the blot. Identical results were obtained when elution of the affinity column was with HA peptide instead of TEV protease (data not shown).
our control substrate (Sec61b-DTMD) are consistent with earlier estimates with this same in vitro system 15 . However, the unexpectedly long termination rate of Sec61b suggests that the TMD slows this reaction. The magnitude of termination delay seen for Sec61b (about 1 min) is comparable to the elongation 'arrest' mediated by SRP measured under similar conditions in this same system 16 . This provides a plausible explanation for how the Bat3 complex could have sufficient time to be recruited to RNCs containing a TMD inside the ribosomal tunnel. The sequence parameters that modulate termination remain to be established, but they are unlikely to depend solely on simple hydrophobicity, given earlier studies showing similar termination delays by relatively hydrophilic sequences 17 .
Our findings explain how the hydrophobic TMDs of TA proteins are safely shielded from inappropriate interactions and aggregation during their delivery to the ER membrane ( Fig. 4c ). Our working model posits that the TMD is shielded throughout targeting, first by the ribosome, then by the Bat3 complex, and finally by TRC40. The sequential handoffs of substrate between these complexes are likely to be tightly regulated to prevent exposure of the TMD to aqueous solution. Perhaps the Bat3 complex regulates the nucleotide cycle and/or conformation of TRC40 to facilitate its loading with substrate. On the basis of recent crystal structures of Get3 (refs 18-22) , efficient substrate loading probably requires a nucleotide-dependent transition from an 'open' to a 'closed' conformation 18, 19 that is perhaps aided by the Bat3 complex. In the absence of this activity, capture by TRC40 would be slower, explaining why it cannot operate efficiently in the presence of competing cytosolic factors but does manage in a purified system (data not shown).
A role for the Bat3 complex in TA protein targeting may therefore not be absolutely essential 23 but would increase fidelity and efficiency. Such a function would seem to be highly conserved, because yeasts have a homologous complex (Get4 and Get5) that shows genetic, physical and functional interactions with Get3 (refs 5-10, 12, 13) and whose absence can lead to aggregation and partial mislocalization of TA proteins [5] [6] [7] . Thus, the Bat3 complex seems to represent a conserved TMD-selective chaperone that acts at the ribosome. Where on the ribosome the Bat3 complex binds, how it is recruited when a TMD is inside the ribosomal tunnel, and how its function is coordinated with several other ribosome-associating factors including SRP 24 , nascent polypeptide-associated complex 25 and ribosome-associated complex 26 , remain important questions for future studies 27 .
METHODS SUMMARY
Reagents and standard methods. Antibodies against Bat3 and Ubl4A were produced in rabbits immunized with recombinant Bat3 fragment (residues 1-250) or full-length Ubl4A, respectively. TRC35 antibodies were against a synthetic peptide (NH 2 -CGSPIELD-COOH) conjugated to keyhole-limpet haemocyanin. In vitro transcription, translation in reticulocyte lysate, sucrosegradient fractionation, chemical crosslinking and immunoprecipitation were performed as described previously 2 . RNCs were generated by transcription and translation of PCR products lacking a stop codon and were sucrose-gradient purified for use in the capture assay. CTAB precipitation of tRNA-associated polypeptides has been described previously 28 . RNC release assay. 35 S-labelled RNCs were incubated with the indicated additions for 15 min at 32 uC. Standard assay conditions were 100 mM potassium acetate, 20 mM HEPES pH 7.4, 7 mM magnesium acetate. The energy-regenerating system consisted of 1 mM ATP, 1 mM GTP, 10 mM creatine phosphate, 40 mg ml 21 creatine kinase. The base cytosolic fraction was prepared from reticulocyte lysate that was bound and eluted from DEAE-Sepharose to remove haemoglobin and concentrated to half the original volume. Immunodepletions from this lysate employed immobilized antibodies. After RNC release, crosslinking was performed with 250 mM bismaleimidohexane (a homo-bifunctional cysteine-reactive crosslinker) on ice for 30 min and quenched with 25 mM 2-mercaptoethanol. Purification of the Bat3 complex. Reticulocyte lysate was bound to phenyl-Sepharose, washed in 50 mM HEPES pH 7.4 and eluted with 1% Triton X-100, 50 mM HEPES pH 7.4. The eluate was bound and acid-eluted from anti-Bat3 affinity resin to identify interacting proteins by mass spectrometry. Functional Bat3 complex was isolated from the phenyl-Sepharose fraction with anti-TRC35 resin, eluted with immunizing peptide, and concentrated by binding and elution from S-Sepharose. RNC purification. Affinity purification of size-fractionated RNCs was performed essentially as described previously 24 , but with an antibody against the amino terminus of Sec61b and elution with immunizing peptide. The final RNCs were sedimented to remove any spontaneously released polypeptides. diagram of Sec61b synthesis, illustrating that nascent chains competent for recruitment of the Bat3 complex would be almost full-length and contain a covalently associated tRNA (red star). Such recruitment-competent polypeptides should migrate on gels close to the full-length size but should be precipitated by CTAB, which selectively precipitates tRNA-associated proteins. b, Time course of Sec61b and Sec61b(DTMD) (both tagged at the C terminus with the same 12-residue epitope tag) synthesized at 25 uC in reticulocyte lysate. At each time point, samples were analysed directly or after CTAB precipitation. The proportion of total full-length polypeptide that was precipitated by CTAB is plotted. The dashed lines indicate theoretical expectations ( Supplementary Fig. 15 ) for a t 1/2 of translational termination of 15 and 60 s. c, Model for shuttling of TA proteins from the ribosome to TRC40 by means of a pre-targeting intermediate involving recruitment of the Bat3 complex to the ribosome.
